Cargando…
Cancer Stem Cells and Neuroblastoma: Characteristics and Therapeutic Targeting Options
The majority of embryonal tumors or childhood blastomas derive from pluripotent progenitors or fetal stem cells that acquire cancer stem cell (CSC) properties: multipotency, self-renewal ability, metastatic potential, chemoresistance, more pronounced levels of drug transporters, enhanced DNA-damage...
Autores principales: | Veschi, Veronica, Verona, Francesco, Thiele, Carol J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877479/ https://www.ncbi.nlm.nih.gov/pubmed/31803140 http://dx.doi.org/10.3389/fendo.2019.00782 |
Ejemplares similares
-
High-SETD8 inactivates p53 in neuroblastoma
por: Veschi, Veronica, et al.
Publicado: (2017) -
Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis
por: Veschi, Veronica, et al.
Publicado: (2020) -
Targeting MYCN in Pediatric and Adult Cancers
por: Liu, Zhihui, et al.
Publicado: (2021) -
Treatment Options for Lipodystrophy in Children
por: Mainieri, Francesca, et al.
Publicado: (2022) -
Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting
por: Farina, Antonietta Rosella, et al.
Publicado: (2021)